NFKB1 and cancer: Some signaling pathways are recurrently altered in many cancers, as those involving p53, NF-kB, receptor tyrosine kinases (RTKs), Wnt, transforming growth factor-b (TGF-β) IFN and Akt, which are significantly influenced by the activity of DUBs.